The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Type 1 Diabetes Is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN)
Open accessAbstract
OBJECTIVE: This study was conducted to determine if type 1 diabetes is associated with an increased risk of fracture across the life span. RESEARCH DESIGN AND METHODS: This population-based cohort study used data from The Health Improvement Network (THIN) in the U.K. (data from 1994 to 2012), in which 30,394 participants aged 0–89 years with type 1 diabetes were compared with 303,872 randomly selected age-, sex-, and practice-matched participants without diabetes. Cox regression analysis was used to determine hazard ratios (HRs) for incident fracture in participants with type 1 diabetes. RESULTS: A total of 334,266 participants, median age 34 years, were monitored for 1.9 million person-years. HR were lowest in males and females age <20 years, with HR 1.14 (95% CI 1.01–1.29) and 1.35 (95% CI 1.12–1.63), respectively. Risk was highest in men 60–69 years (HR 2.18 [95% CI 1.79–2.65]), and in women 40–49 years (HR 2.03 [95% CI 1.73–2.39]). Lower extremity fractures comprised a higher proportion of incident fractures in participants with versus those without type 1 diabetes (31.1% vs. 25.1% in males, 39.3% vs. 32% in females; P < 0.001). Secondary analyses for incident hip fractures identified the highest HR of 5.64 (95% CI 3.55–8.97) in men 60–69 years and the highest HR of 5.63 (95% CI 2.25–14.11) in women 30–39 years. CONCLUSIONS: Type 1 diabetes was associated with increased risk of incident fracture that began in childhood and extended across the life span. Participants with type 1 diabetes sustained a disproportionately greater number of lower extremity fractures. These findings have important public health implications, given the increasing prevalence of type 1 diabetes and the morbidity and mortality associated with hip fractures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Vestergaard, P. (2007) · Osteoporosis International · doi:10.1007/s00198-006-0253-4 · Cited by 1,808
Systematic Review of Type 1 and Type 2 Diabetes Mellitus and Risk of Fracture
Janghorbani, M., Van Dam, R. M., Willett, W. C., & Hu, F. B. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm106 · Cited by 1,209
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
The DIAMOND Project Group (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01925.x · Cited by 1,085
Bone mineral accrual from 8 to 30 years of age: An estimation of peak bone mass
Baxter-Jones, A. D., Faulkner, R. A., Forwood, M. R., Mirwald, R. L., & Bailey, D. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.412 · Cited by 683
Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women
Nicodemus, K. K., & Folsom, A. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1192 · Cited by 568
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Diabetologia · doi:10.1007/s00125-005-1786-3 · Cited by 557
The Read clinical classification.
Chisholm, J. (1990) · BMJ · doi:10.1136/bmj.300.6732.1092 · Cited by 504
Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey
Forsén, L., Meyer, H. E., Midthjell, K., & Edna, T.-H. (1999) · Diabetologia · doi:10.1007/s001250051248 · Cited by 381
Bone, sweet bone—osteoporotic fractures in diabetes mellitus
Hamann, C., Kirschner, S., Günther, K.-P., & Hofbauer, L. C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.233 · Cited by 380
Trends in the prevalence and incidence of diabetes in the UK: 1996–2005
González, E. L. M., Johansson, S., Wallander, M.-A., & Rodríguez, L. A. G. (2009) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2008.080382 · Cited by 297
Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice
Botolin, S., & McCabe, L. R. (2007) · Endocrinology · doi:10.1210/en.2006-1006 · Cited by 266
The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
Currie, C. J., Peyrot, M., Morgan, C. L., Poole, C. D., Jenkins-Jones, S., Rubin, R. R., Burton, C. M., & Evans, M. (2012) · Diabetes Care · doi:10.2337/dc11-1277 · Cited by 252
Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non‐osmotic pathways
Botolin, S., & McCabe, L. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20842 · Cited by 250
Elevated Hip Fracture Risk in Type 1 Diabetic Patients
Miao, J., Brismar, K., Nyrén, O., Ugarph-Morawski, A., & Ye, W. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2850 · Cited by 199
Streptozotocin, Type I Diabetes Severity and Bone
Motyl, K. J., & McCabe, L. R. (2009) · Biological Procedures Online · doi:10.1007/s12575-009-9000-5 · Cited by 151
Young Women With Type 1 Diabetes Have Lower Bone Mineral Density That Persists Over Time
Mastrandrea, L. D., Wactawski‐Wende, J., Donahue, R. P., Hovey, K. M. O., Clark, A., & Quattrin, T. (2008) · Diabetes Care · doi:10.2337/dc07-2426 · Cited by 135
Hothersall, E. J., Livingstone, S. J., Looker, H. C., Ahmed, S. F., Cleland, S., Leese, G., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Philip, S., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2118 · Cited by 128
Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes?
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9450-4 · Cited by 122
Neumann, T. E., Lodes, S., Kästner, B., Franke, S., Kiehntopf, M., Lehmann, T., Müller, U., Wolf, G., & Sämann, A. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2631-7 · Cited by 121
Strotmeyer, E. S., Cauley, J. A., Orchard, T. J., Steenkiste, A. R., & Dorman, J. S. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1353 · Cited by 108
Liao, C., Lin, C., Shih, C.-C., Yeh, C.-C., Chang, Y., Lee, Y., & Chen, T.-L. (2014) · Diabetes Care · doi:10.2337/dc13-2957 · Cited by 96
Imkampe, A. ‐., & Gulliford, M. C. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03288.x · Cited by 91
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s014 · Cited by 82
Denburg, M., Leonard, M. B., Haynes, K., Tuchman, S., Tasian, G. E., Justine Shults, A., & Copelovitch, L. A. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04340514 · Cited by 79
Self-citationEnd-stage renal disease and survival in people with diabetes: a national database linkage study
Bell, S., Fletcher, E. H., Brady, I., Looker, H. C., Levin, D., Joss, N., Traynor, J. P., Metcalfe, W., Conway, B. R., Livingstone, S. J., et al. (2014) · QJM · doi:10.1093/qjmed/hcu170 · Cited by 74
The impact of treatment non-compliance on mortality in people with type 1 diabetes
Currie, C. J., Peyrot, M. F., Morgan, C. L., Poole, C., Jenkins‐Jones, S., Rubin, R. R., Burton, C. M., & Evans, M. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.10.006 · Cited by 74
Roggen, I., Gies, I., Vanbesien, J., Louis, O., & Schepper, J. D. (2013) · Hormone Research in Paediatrics · doi:10.1159/000346686 · Cited by 65
Tsampalieros, A. K., Gupta, P., Denburg, M., Justine Shults, A., Zemel, B. S., Mostoufi‐Moab, S., Wetzsteon, R. J., Herskovitz, R. M., Whitehead, K., & Leonard, M. B. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1785 · Cited by 65
Self-citationDiuretic initiation and the acute risk of hip fracture
Berry, S. D., Zhu, Y., Choi, H. K., Kiel, D. P., & Zhang, Y. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2053-3 · Cited by 61
Loss of Insulin Receptor in Osteoprogenitor Cells Impairs Structural Strength of Bone
Thrailkill, K. M., Bunn, R. C., Lumpkin, C. K., Wahl, E. C., Cockrell, G. E., Morris, L. M., Kahn, C. R., Fowlkes, J. L., & Nyman, J. S. (2014) · Journal of Diabetes Research · doi:10.1155/2014/703589 · Cited by 48
Osteo-promoting effects of insulin-like growth factor I (IGF-I) in a mouse model of type 1 diabetes
Fowlkes, J. L., Nyman, J. S., Bunn, R. C., Jo, C., Wahl, E. C., Liu, L., Cockrell, G. E., Morris, L. M., Lumpkin, C. K., & Thrailkill, K. M. (2013) · Bone · doi:10.1016/j.bone.2013.07.017 · Cited by 33
Exposure to CYP3A4‐inducing and CYP3A4‐non‐inducing antiepileptic agents and the risk of fractures
Schelleman, H., Pollard, J. R., Newcomb, C. W., Markowitz, C., Bilker, W. B., Leonard, M. B., & Hennessy, S. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2141 · Cited by 19
Self-citationToppe, C., Möllsten, A., Schön, S., Jönsson, A., & Dahlquist, G. G. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.10.007 · Cited by 10
Cited by
Mechanisms of diabetes mellitus-induced bone fragility
On behalf of the IOF Bone and Diabetes Working Group, Napoli, N., Chandran, M., Pierroz, D. D., Abrahamsen, B., Schwartz, A. V., & Ferrari, S. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.153 · Cited by 1,107
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
Diagnosis and management of bone fragility in diabetes: an emerging challenge
Ferrari, S. L., Abrahamsen, B., Napoli, N., Akesson, K., Chandran, M., Eastell, R., El-Hajj Fuleihan, G., Josse, R., Kendler, D. L., Kraenzlin, M., et al. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4650-2 · Cited by 398
Japanese Clinical Practice Guideline for Diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13306 · Cited by 341
Metadata
- Authors
- Weber, D. R., Haynes, K., Leonard, M. B., Willi, S. M., & Denburg, M. R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-07-27
- Volume
- 38
- Issue
- 10
- Pages
- 1913-1920
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1948111189
- Cited by
- 274
- References
- 35
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.